Cargando…

Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?

In patients with IgA nephropathy (IgAN), circulatory IgA1 and IgA1 in mesangial deposits contain elevated amounts of galactose-deficient IgA1 (Gd-IgA1). We hypothesized that a fraction of Gd-IgA1 from the glomerular deposits and/or circulation may be excreted into the urine and thus represent a dise...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suzuki, Hitoshi, Allegri, Landino, Suzuki, Yusuke, Hall, Stacy, Moldoveanu, Zina, Wyatt, Robert J., Novak, Jan, Julian, Bruce A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5018335/ https://www.ncbi.nlm.nih.gov/pubmed/27647947 http://dx.doi.org/10.1155/2016/7806438

Ejemplares similares

Autoantibodies Specific for Galactose-Deficient IgA1 in IgA Vasculitis With Nephritis
por: Suzuki, Hitoshi, et al.
Publicado: (2019)

Galactose-Deficient IgA1 as a Candidate Urinary Marker of IgA Nephropathy
por: Fukao, Yusuke, et al.
Publicado: (2022)

Serial Galactose-Deficient IgA1 Levels in Children with IgA Nephropathy and Healthy Controls
por: Sanders, John T., et al.
Publicado: (2017)

Serum Galactose-Deficient IgA1 Level Is Not Associated with Proteinuria in Children with IgA Nephropathy
por: Hastings, M. Colleen, et al.
Publicado: (2012)

Association of IgG co-deposition with serum levels of galactose-deficient IgA1 in pediatric IgA nephropathy
por: Eison, T. Matthew, et al.
Publicado: (2012)

Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients with IgA nephropathy
por: Placzek, William J., et al.
Publicado: (2018)

The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression
por: Zhao, Na, et al.
Publicado: (2012)

Clinical Significance of the Intensity of Glomerular Galactose-Deficient IgA1 Deposition in IgA Nephropathy
por: Nakayama, Maiko, et al.
Publicado: (2022)

Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy
por: Yasutake, Junichi, et al.
Publicado: (2015)

Changes in Nephritogenic Serum Galactose-Deficient IgA1 in IgA Nephropathy following Tonsillectomy and Steroid Therapy
por: Nakata, Junichiro, et al.
Publicado: (2014)

cnm-positive Streptococcus mutans is associated with galactose-deficient IgA in patients with IgA nephropathy
por: Misaki, Taro, et al.
Publicado: (2023)

Inhibition of STAT3 Signaling Reduces IgA1 Autoantigen Production in IgA Nephropathy
por: Yamada, Koshi, et al.
Publicado: (2017)

Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression
por: Maixnerova, Dita, et al.
Publicado: (2019)

Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy
por: Nihei, Yoshihito, et al.
Publicado: (2023)

Correction: Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression
por: Maixnerova, Dita, et al.
Publicado: (2019)

Enzymatic Sialylation of IgA1 O-Glycans: Implications for Studies of IgA Nephropathy
por: Takahashi, Kazuo, et al.
Publicado: (2014)

Renal pathological analysis using galactose-deficient IgA1-specific monoclonal antibody is a strong tool for differentiation of primary IgA nephropathy from secondary IgA nephropathy
por: Lee, Mingfeng, et al.
Publicado: (2020)

The Origin and Activities of IgA1-Containing Immune Complexes in IgA Nephropathy
por: Knoppova, Barbora, et al.
Publicado: (2016)

Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy
por: Wada, Yukihiro, et al.
Publicado: (2018)

Cellular Signaling and Production of Galactose-Deficient IgA1 in IgA Nephropathy, an Autoimmune Disease
por: Reily, Colin, et al.
Publicado: (2014)

Clinical Significance of Serum Galactose-Deficient IgA1 Level in Children with IgA Nephropathy
por: Irabu, Hitoshi, et al.
Publicado: (2020)

ELL2 Is Downregulated and Associated with Galactose-Deficient IgA1 in IgA Nephropathy
por: Liu, Youxia, et al.
Publicado: (2019)

Clinical Relevance of Serum Galactose Deficient IgA1 in Patients with IgA Nephropathy
por: Kim, Jin Sug, et al.
Publicado: (2020)

Uncoupling of Glomerular IgA Deposition and Disease Progression in Alymphoplasia Mice with IgA Nephropathy
por: Aizawa, Masashi, et al.
Publicado: (2014)

Identification of IgA autoantibodies targeting mesangial cells redefines the pathogenesis of IgA nephropathy
por: Nihei, Yoshihito, et al.
Publicado: (2023)

Galactose-Deficient IgA1-Specific Antibody Recognizes GalNAc-Modified Unique Epitope on Hinge Region of IgA1
por: Yamasaki, Kohei, et al.
Publicado: (2018)

Helicobacter pylori infection is associated with elevated galactose-deficient IgA1 in IgA nephropathy
por: Liu, Xing-Zi, et al.
Publicado: (2020)

Assay for galactose-deficient IgA1 enables mechanistic studies with primary cells from IgA nephropathy patients
por: Reily, Colin, et al.
Publicado: (2018)

Serum levels of galactose-deficient immunoglobulin (Ig) A1 and related immune complex are associated with disease activity of IgA nephropathy
por: Suzuki, Yusuke, et al.
Publicado: (2014)

Special Issue: New Insights into the Pathogenesis and Therapies of IgA Nephropathy
por: Suzuki, Hitoshi, et al.
Publicado: (2022)

Effect of Immunosuppressive Drugs on the Changes of Serum Galactose-Deficient IgA1 in Patients with IgA Nephropathy
por: Kim, Min Jeong, et al.
Publicado: (2016)

Utility of remission criteria for the renal prognosis of IgA nephropathy
por: Matsuzaki, Keiichi, et al.
Publicado: (2021)

Galactose-deficient IgA1 and nephritis-associated plasmin receptors as markers for IgA-dominant infection-related glomerulonephritis: A case report
por: Han, Wei, et al.
Publicado: (2021)

Serum under-O-glycosylated IgA1 level is not correlated with glomerular IgA deposition based upon heterogeneity in the composition of immune complexes in IgA nephropathy
por: Satake, Kenji, et al.
Publicado: (2014)

The Role of IgA in the Pathogenesis of IgA Nephropathy
por: Perše, Martina, et al.
Publicado: (2019)

Mesangial cells from patients with IgA nephropathy have increased susceptibility to galactose-deficient IgA1
por: Ebefors, Kerstin, et al.
Publicado: (2016)

Alternative Complement Pathway Is Activated and Associated with Galactose-Deficient IgA(1) Antibody in IgA Nephropathy Patients
por: Chiu, Yen-Ling, et al.
Publicado: (2021)

Phosphatase control of cytokine-mediated overproduction of galactose-deficient IgA1, the main autoantigen in IgA nephropathy
por: Reily, Colin, et al.
Publicado: (2022)

Pathological Role of Tonsillar B Cells in IgA Nephropathy
por: Suzuki, Yusuke, et al.
Publicado: (2011)

GWAS for serum galactose-deficient IgA1 implicates critical genes of the O-glycosylation pathway
por: Kiryluk, Krzysztof, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_29s4foa6093hmm1ffa1gvrq3p9